As filed with the U.S. Securities and Exchange Commission on February 23, 2026. Registration No. 333-292285 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ––––––––––––––––––––––––––––––––––––––– Brookline Capital Acquisition Corp II (Exact name of registrant as specified in its charter) ––––––––––––––––––––––––––––––––––––––– | Cayman Islands | 6770 | N/A | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standa ...

Accendra Health's Investment Potential: A Deep Dive into ACH on the NYSEAccendra Health, trading under the symbol ACH on the NYSE, is a company that has recently caught the attention of investors. On February 22, 2026, UBS maintained its "Buy" rating for ACH, even though it lowered the price target from $4 to $3. At that time, the stock was priced at $2.61. Accendra Health has faced challenges, but there are signs of potential growth.The stock has been upgraded to a "Buy" rating after a period of underperfo ...

Core Viewpoint - UnitedHealth Group Incorporated (NYSE:UNH) is experiencing significant challenges, with a notable stock decline and disappointing financial guidance for 2026 [2][3]. Financial Performance - The company reported fourth-quarter results with revenue of $113.2 billion, falling short of the $113.8 billion expected by analysts [3]. - Despite beating earnings estimates by a small margin, the overall sentiment remains negative due to the company's outlook [2][3]. Future Outlook - Management projects full-year 2026 revenue of $439 billion, which is approximately $15 billion lower than Wall Street's expectations [3]. - If this revenue estimate holds, it would represent the company's first annual revenue decline in over 30 years, contributing to the recent stock weakness [3]. Analyst Revisions - Mizuho reduced its price target for UNH from $430 to $350 while maintaining an Outperform rating, citing a slower-than-expected earnings recovery [4]. - Truist analyst David MacDonald lowered the price target from $410 to $370 but kept a Buy rating, reflecting updated estimates following the Q4 results and 2026 guidance [5]. Company Overview - UnitedHealth operates in the healthcare sector with various business lines, including Optum Health, Optum Insight, and Optum Rx, as well as UnitedHealthcare, which serves multiple markets [6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Ardent Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Ardent Health securities between July 18, 2024, and November 12, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 9, 2026 [3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering significant amounts for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable and the adequacy of its professional malpractice liability insurance, which led to inflated reports of accounts receivable and delayed recognition of losses [5].

Hinge Health, Inc. (NYSE:HNGE) is among the 11 Newly-Listed NYSE Stocks to Buy Now. KeyBanc Reduces its Price Target on Hinge Health, Inc. (HNGE) to $55 and Maintains an Overweight Rating On February 11, 2026, KeyBanc reduced its price target on Hinge Health, Inc. (NYSE:HNGE) to $55 from $70 and maintained an Overweight rating. That same day, Evercore ISI analyst Elizabeth Anderson lowered the price target to $50 from $65 while keeping an Outperform rating. Elizabeth Anderson said Hinge Health exceeded ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities between July 18, 2024, and November 12, 2025, of the March 9, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Ardent Health securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by March 9, 2026, to serve as lead plaintiff [2] - The lawsuit claims that Ardent Health made misrepresentations regarding its accounts receivable and did not maintain sufficient professional malpractice liability insurance [4] Group 2: Misrepresentation Claims - Defendants allegedly misrepresented the process for determining the collectability of accounts receivable, claiming to use detailed reviews of historical collections, which was not the case [4] - The lawsuit indicates that Ardent Health's accounts receivable framework allowed for inflated reporting of accounts receivable and delayed recognition of losses on uncollectible accounts [4] - The firm did not maintain adequate professional malpractice liability insurance to cover claims arising from its operations, contrary to public statements [4] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [3] - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3] - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in representing clients [3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities between July 18, 2024, and November 12, 2025, of the March 9, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Ardent Health securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court by March 9, 2026, to serve as lead plaintiff, representing other class members [3]. Group 2: Case Background - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable, claiming an active monitoring process and sufficient malpractice liability insurance, which were not true [5]. - It was revealed that Ardent Health's accounts receivable framework allowed for inflated reporting, delaying the recognition of losses on uncollectible accounts, and that the company did not maintain adequate malpractice liability insurance [5].

BrightSpring Health Services, Inc. (NASAQ:BTSG) is among the Most Volatile Stocks. On January 27, 2026, TD Cowen upgraded BrightSpring Health Services, Inc. (NASDAQ:BTSG)’s price objective to $46 from $42 while keeping a Buy rating. The firm noted strong specialty generics trends as a driver of ongoing Q4 momentum. On January 23, 2026, BMO Capital boosted BrightSpring Health Services, Inc. (NASDAQ:BTSG)’s price target from $40 to $46 and maintained its Outperform rating. BMO Capital noted the firm’s com ...

Cardinal Health, Inc. (NYSE:CAH) is included among the 16 Best Dividend Stocks with Rising Payouts. Wells Fargo Raises Outlook on Cardinal Health (CAH), Cites Broad Business Strength On February 10, Wells Fargo raised its price recommendation on Cardinal Health, Inc. (NYSE:CAH) to $256 from $237. The firm reiterated its Overweight rating on the stock. The decision followed a strong Q2 performance, which led the firm to lift its earnings estimates. Wells Fargo pointed to broad strength across the business ...

Hagens Berman Investigating Claims Against Ardent Health (ARDT) Over Alleged $97M Accounting Shock and "180-Day Cliff" Reserves [Accessibility Statement] Skip NavigationARDT Investors with Losses Encouraged to Contact the FirmSAN FRANCISCO, Feb. 20, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors in Ardent Health, Inc. (NYSE: ARDT) regarding the March 9, 2026, lead plaintiff deadline in a pending securities class action the company and certain of its top execut ...